• $10M NIH Grant Aims to Identify Genes Linked to COPD, Other Diseases
  • Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients
  • Pulmatrix Licenses RespiVert’s Kinase Inhibitor Therapies for COPD and Other Lung Diseases
  • BCBSTX to Invest $10 Million in COPD and Chronic Diabetic Kidney Disease Prevention in Texas
  • Verona Pharma Announces New Clinical Trial for Inhaled Lung Therapy RPL554
  • Sunovion Receives FDA Letter Advancing Regulatory Status of SUN-101/eFlow Therapy to Treat COPD
  • Philips Acquires Airway Clearance Device Maker RespirTech and Expands COPD Therapeutic Portfolio
  • Philips-sponsored Study Supports Use of Home Noninvasive Ventilation for COPD Treatment
  • Using Ventilator to Control Oxygen May Be COPD Game-changer, Study Suggests
  • Company to Showcase Latest Lung Function Tests at ATS 2017 Conference
  • Sunovion to Present Outcomes of Nebulized LAMA Bronchodilator Therapy for COPD at ATS 2017
  • Pulmatrix Receives U.S. Patent for its Inhaled Bronchodilator COPD Therapy PUR0200